Trial Profile
A Multicentre, Randomized, Double-blind, Phase III Study of The Comparative Immunogenicity, Safety and Tolerability of Two Japanese Encephalitis Vaccines (ChimeriVax-JE and JE-VAX)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jun 2016
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics; Registrational
- Sponsors Sanofi
- 12 Jan 2007 Status change
- 16 Nov 2006 Status change
- 14 Nov 2006 The expected completion date for this trial is now 1 Apr 2007.